Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Laura Van Metre Baum

Clinical Trials

    • Cancer(4)
  • Phase 1 Cancers

    A Phase 1 First-in Human, Multi-Center, Open Label Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination With ABBV-181 in Subjects With Locally Advanced or Metastatic Solid Tumors

    • Ages18 years and older
    • GenderBoth
  • Pancreatic Cancer

    A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

    • Colorectal Cancer

      Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

      • Thyroid and Other Endocrine Cancers, Pancreatic Cancer

        Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

        • About Us
        • Contact Us
        • Donate
        • Referring Doctors
        • Clinical Keywords

        333 Cedar St.

        New Haven, CT 06510

        • Yale School of Medicine
        • Yale University
        • Terms & Privacy Policies
        • Accessibility at YSM
        • Patient Rights
        • HIPAA at Yale
        • Non-discrimination Statement
        Copyright 2025 Yale Medicine